Jane A. Gross - 22 May 2024 Form 4 Insider Report for aTYR PHARMA INC (LIFE)

Role
Director
Signature
/s/ Nancy E. Denyes, as Attorney-in-Fact
Issuer symbol
LIFE
Transactions as of
22 May 2024
Transactions value $
$0
Form type
4
Filing time
23 May 2024, 19:27:41 UTC
Previous filing
19 May 2023
Next filing
17 Mar 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LIFE Stock Option (right to buy) Award $0 +24K $0.00 24K 22 May 2024 Common Stock 24K $1.86 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 22, 2025 or (ii) the Issuer's 2025 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors.